Suchergebnisse - "Rimassa, Lorenza"

PubPharm (20)

1

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours

enthalten in: Journal of hepatology | 2024

von Celsa, C. | Cabibbo, G. | Fulgenzi, C. | +69

2

Plain language summary of the HIMALAYA study : tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer)

enthalten in: Future oncology (London, England) | 2023

von Abou-Alfa, G. | Lau, G. | Kudo, M. | +27

3

Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors

enthalten in: Frontiers in oncology | 2023

von Wu, Y. | van Hyfte, G. | Özbek, U. | +22

4

Immunotherapy in hepatocellular carcinoma : how will it reshape treatment sequencing?

enthalten in: Therapeutic advances in medical oncology | 2023

von Cammarota, A. | Zanuso, V. | Manfredi, G. | +3

5

Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization

enthalten in: Journal of clinical medicine | 2022

von Masetti, C. | Pugliese, N. | Lofino, L. | +10

6

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab

enthalten in: Cancers | 2022

von Wu, Y. | Fulgenzi, C. | D'Alessio, A. | +32

7

Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment

enthalten in: Journal of personalized medicine | 2022

von Personeni, N. | Pressiani, T. | Zanuso, V. | +10

8

Outcome of liver cancer patients with SARS-CoV-2 infection : An International, Multicentre, Cohort Study

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2022

von Muñoz-Martínez, S. | Sapena, V. | Forner, A. | +52

9

The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma

enthalten in: Cancers | 2021

von Muhammed, A. | Fulgenzi, C. | Dharmapuri, S. | +36

10

Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors

enthalten in: Cancers | 2021

von Personeni, N. | Pressiani, T. | D'Alessio, A. | +13